Valparin: Compound Profile
Valparin 500 mg pharmaceutical is a pharmaceutical-grade sodium valproate research compound utilised in laboratory investigations of neurological pathways and anticonvulsant mechanisms. Sodium valproate belongs to the class of short-chain fatty acid derivatives and serves as a valuable tool for researchers studying epileptogenic processes, mood stabilisation pathways, and histone deacetylase inhibition in cellular models. Each pharmaceutical tablet contains precisely 500 mg of active sodium valproate, enabling consistent experimental protocols across research applications. At Stroid UK Shop, we supply this pharmaceutical-grade compound exclusively for in-vitro laboratory research purposes.
Laboratory Research Applications
Research scientists examine Valparin 500 mg pharmaceutical in studies investigating GABAergic neurotransmission enhancement and voltage-gated sodium channel modulation mechanisms. The compound demonstrates particular utility in epilepsy research models where investigators analyse anticonvulsant efficacy and neuronal excitability suppression pathways. Cellular biology researchers study sodium valproate’s histone deacetylase inhibitory properties and their effects on gene expression regulation. Our miscellaneous research compounds category includes various pharmaceutical-grade materials for neurological research applications. Additionally, researchers exploring mood disorder mechanisms examine valproate’s effects on neurotransmitter systems alongside other compounds available in our SARMs and peptides collections for comprehensive neurobiological investigations.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Sodium Valproate |
| Strength per Tablet | 500 mg |
| CAS Number | 1069-66-5 |
| Molecular Formula | C₈H₁₅NaO₂ |
| Molecular Weight | 166.19 g/mol |
| Form | Pharmaceutical tablets |
| Purity | Pharmaceutical grade |
| Storage | Room temperature, dry environment |
Compliance and Laboratory Use
This Valparin 500 mg pharmaceutical compound is manufactured for exclusive use in controlled laboratory environments and in-vitro research applications. The product is not intended for human consumption, animal testing, or any clinical applications outside authorised research facilities. Researchers must ensure compliance with institutional guidelines and obtain appropriate permits before studying sodium valproate compounds. All investigations should follow established laboratory safety protocols when handling pharmaceutical-grade research materials.
